Loading...

Rising Regulation And Pricing Pressures Will Hinder Future Performance

Published
13 Jul 25
Updated
14 May 26
Views
223
14 May
US$441.73
AnalystLowTarget's Fair Value
US$420.19
5.1% overvalued intrinsic discount
Loading
1Y
-43.4%
7D
-6.2%

Author's Valuation

US$420.195.1% overvalued intrinsic discount

AnalystLowTarget Fair Value

Last Update 14 May 26

Fair value Decreased 19%

AXON: Sector Multiple Compression Will Meet Expanding AI Public Safety Platform

Narrative Update: Axon Enterprise

Axon Enterprise's analyst price targets have been revised lower, with the model's fair value estimate moving from about $521 to about $420 as analysts temper revenue growth, margin, and future P/E assumptions following a broad wave of target cuts, even as many still highlight solid execution and long term opportunities.

Analyst Commentary

Recent Street research on Axon Enterprise points to a broad reset in expectations, with many firms trimming price targets even when they maintain positive ratings. The shift reflects a mix of valuation discipline and recognition that sector wide multiples have come in, rather than a uniform change in views on Axon's business direction.

Several large banks, including JPMorgan, Morgan Stanley, Goldman Sachs, and others, have reduced targets by varying amounts, in some cases by more than US$100 per share. At the same time, a few firms still highlight Axon's long term potential in areas such as annual recurring revenue, data assets, and product expansion, while moderating the multiples they are willing to apply.

Some research notes point to Q4 results and updated long term targets that were described as better than expected, along with strong bookings and EBITDA margins. However, even these more constructive views are paired with lower target prices, reflecting a tighter stance on valuation multiples across software and related sectors.

Overall, the research set describes a company that many on the Street still see as well exposed to themes like public safety technology and AI, but where the stock's previous valuation leaves less room for execution slip ups or sector wide de rating.

Bearish Takeaways

  • Bearish analysts have cut targets aggressively, including US$175 at JPMorgan and US$90 at Goldman Sachs, which signals that prior valuation levels are viewed as too demanding relative to current assumptions.
  • Multiple target cuts of US$100 or more from various firms point to concern that Axon's prior P/E and revenue multiples may not be sustainable if sector multiples remain compressed.
  • Some bearish analysts frame their reductions around sector re rating and negative sentiment. This can increase the risk that any execution hiccup or slower than modeled growth would have an outsized effect on the stock.
  • Even where firms acknowledge strong fundamentals or better than expected results, the decision to lower targets highlights lingering caution around how much investors should pay today for Axon's long dated growth story.

What's in the News

  • Axon Enterprise raised its full year 2026 earnings guidance, with expected revenue growth in a range of 30% to 32%, compared with prior guidance of 27% to 30%.
  • The company introduced new AI powered capabilities during Axon Week 2026. These aim to help public safety agencies detect incidents earlier, access information faster, and coordinate responses across live video, 911, and reporting workflows.
  • Axon announced Axon Vision for real time awareness from live video, using AI to identify critical activity across large CCTV networks and support quicker operator decision making.
  • Axon expanded Axon Assistant across its ecosystem, offering CJIS compliant access to agency data to support tasks such as BOLO alerts, case research, and coordination between field and back office teams.
  • Rahul Kishore of Epicenter Capital highlighted Axon Enterprise as a stock idea at the Sohn conference, focusing on its role in tasers and police body cameras (Business Insider).

Valuation Changes

  • Fair Value: Model fair value moved from about $521.24 to about $420.19, a reduction of roughly 19%.
  • Discount Rate: The discount rate has risen slightly from 7.66% to about 7.97%.
  • Revenue Growth: The assumed long-term revenue growth rate has eased from about 28.26% to about 26.73%.
  • Net Profit Margin: The assumed net profit margin has fallen significantly from about 7.85% to about 3.95%.
  • Future P/E: The future P/E multiple has increased from about 122.9x to about 196.4x, implying a higher valuation multiple applied to earnings assumptions.
16 viewsusers have viewed this narrative update

Key Takeaways

  • Growing competition and rapid technology commoditization threaten Axon's hardware and software margins, while evolving regulations and privacy requirements increase compliance costs and restrict product features.
  • Heavy exposure to government contracts, unpredictable procurement cycles, and shifting law enforcement funding priorities heighten risks to revenue stability, growth, and profitability.
  • Rapid adoption of new software, diversified international growth, and a shift to high-margin services are boosting recurring revenue, margins, and long-term market potential.

Catalysts

About Axon Enterprise
    Develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally.
What are the underlying business or industry changes driving this perspective?
  • The rapid commoditization of AI-driven cameras, cloud storage, and real-time analytics threatens to erode Axon's hardware and software competitive advantage, increasing pricing pressure and potentially compressing gross margins as cheaper alternatives become widely available.
  • Strict and evolving data privacy regulations both in the U.S. and internationally may raise Axon's compliance costs substantially over the next several years, force restrictions on product features, and slow digital evidence platform adoption, risking a deceleration in recurring revenue growth and higher operating expenses.
  • Persistent public debate around law enforcement funding and a societal shift toward alternative public safety models could reduce budgets for police equipment, making Axon increasingly vulnerable to contract cancellations, delayed upgrades, or outright cuts which would directly impact future bookings and earnings growth.
  • Axon's heavy reliance on U.S. state and local government contracts exposes it to significant revenue concentration risk, and if even a portion of key agencies postpone or cancel upgrades due to budget constraints or shifting policy, the company may see marked volatility and downward pressure on annual recurring revenue and net margins.
  • Lengthy and unpredictable government procurement cycles, combined with the threat of new budget tightening and increased competition from larger tech and defense firms, could slow the pace of contract wins and reduce Axon's ability to sustain its current high revenue growth rate, putting long-term earnings and margin expansion targets at risk.
Axon Enterprise Earnings and Revenue Growth

Axon Enterprise Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • This narrative explores a more pessimistic perspective on Axon Enterprise compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
  • The bearish analysts are assuming Axon Enterprise's revenue will grow by 26.7% annually over the next 3 years.
  • The bearish analysts assume that profit margins will shrink from 6.9% today to 3.9% in 3 years time.
  • The bearish analysts expect earnings to reach $239.7 million (and earnings per share of $2.78) by about May 2029, up from $206.0 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $803.5 million.
  • In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 197.4x on those 2029 earnings, up from 147.4x today. This future PE is greater than the current PE for the US Aerospace & Defense industry at 35.9x.
  • The bearish analysts expect the number of shares outstanding to grow by 3.53% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.97%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Axon is experiencing rapid adoption of new software products like Draft One and the AI Era Plan, resulting in double the adoption rates versus previous launches and contributing strongly to annual recurring revenue growth, which increases the company's revenue visibility and supports high net retention rates.
  • International expansion is gaining traction, with record Q1 bookings and growing demand in Australia, Latin America, Canada, Asia, the U.K., and Europe, which is diversifying the company's revenue streams away from reliance on U.S. law enforcement and opening substantial new TAM opportunities that can support long-term revenue growth.
  • The mix shift towards software and services, which posted 39% year-over-year growth and maintains gross margins above 80%, is improving overall company margin structure and boosting earnings, especially as recurring subscription revenues climb.
  • Axon's expanding product ecosystem-including integrated body cameras, TASER 10, vehicle intelligence, fixed ALPR cameras, drone detection, and real-time translation-improves cross-selling opportunities and customer retention, driving up average contract values and supporting continued revenue and margin expansion.
  • Secular trends such as heightened public safety investment, government demand for AI-driven digital evidence solutions, and increasing global defense and security budgets are expanding Axon's addressable market and underpinning sustainable long-term revenue and earnings growth.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bearish price target for Axon Enterprise is $420.19, which represents up to two standard deviations below the consensus price target of $662.04. This valuation is based on what can be assumed as the expectations of Axon Enterprise's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $825.0, and the most bearish reporting a price target of just $409.68.
  • In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $6.1 billion, earnings will come to $239.7 million, and it would be trading on a PE ratio of 197.4x, assuming you use a discount rate of 8.0%.
  • Given the current share price of $376.82, the analyst price target of $420.19 is 10.3% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Axon Enterprise?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$662.04
FV
33.3% undervalued intrinsic discount
28.14%
Revenue growth p.a.
1.6k
users have viewed this narrative
1users have liked this narrative
2users have commented on this narrative
96users have followed this narrative
US$606.83
FV
27.2% undervalued intrinsic discount
17.00%
Revenue growth p.a.
209
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative